Article
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
Acta neuropathologica - 8 Dec 2023
Auffret Lucie, Ajlil Yassine, Tauziède-Espariat Arnault, Kergrohen Thomas, Puiseux Chloé, Riffaud Laurent, Blouin Pascale, Bertozzi Anne-Isabelle, Leblond Pierre, Blomgren Klas, Froelich Sébastien, Picca Alberto, Touat Mehdi, Sanson Marc, Beccaria Kévin, Blauwblomme Thomas, Dangouloff-Ros Volodia, Boddaert Nathalie, Varlet Pascale, Debily Marie-Anne, Grill Jacques, Castel David
Abstract excerpt
Diffuse midline gliomas (DMG) H3 K27-altered are incurable grade 4 gliomas and represent a major challenge in neuro-oncology. This tumour type is now classified in four subtypes by the 2021 edition of the WHO Classification of the Central Nervous System (CNS) tumours. However, the H3.3-K27M subgroup still appears clinically and molecularly heterogeneous. Recent publications reported that rare patients presenting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
